Main page content
TI-20-012 Individual Grant Awards
|Award Number||Organization||Grantee State Sort descending||City||Funding amount|
|1 H79 TI083334-01||
During the past two years Alaska has experienced a decrease in opioid misuse related overdose deaths while simultaneously seeing a dramatic increase in stimulant misuse. This project will help Alaska to combat the opioid/stimulant misuse by enriching prevention efforts, enhancing recovery support efforts for individuals experiencing opioid or stimulant use disorders, and the expansion of the addiction treatment workforce to increase the number of Alaskan served. The purpose of the Alaska State Opioid Response project is to reduce opioid overdose-related deaths through the provision of prevention activities for Opioid and or Stimulant Use Disorders; increase access to treatment and recovery supports for those with opioid and stimulant use disorders and to further enhance the Addiction Treatment workforce's proficiency using evidence based practices. To meet these goals Alaska will undertake the following objectives: 1) conduct educational outreach and distribution of Naloxone, 2) screen newborns for substance exposure, 3) enhance the functions of the Prescription Drug Monitoring Program, 4) establish ASAM level 3.3 capabilities within the State, 5) continue development of credentialing standards for peer support specialists, 6) strengthen recovery residences through adding two to rural areas and continue funding for current residences, 7) begin certification of recovery residencies to national standards, 8) increase number of peer support specialists through provided training, 9) provide access to supported employment/education specialists, 10) link providers to Project Echo Opioid and other educational opportunities, 11) host trainings on Evidence Based practices for Addiction Treatment, and 12) publish Medication Assisted Treatment Guide. To achieve these goals and objectives, this project will work in tandem with current state efforts to develop a coordinated recovery-oriented system of care and utilizing several evidence-based practices. Project Echoes as well as other provider educational opportunities, will enhance Alaska's addiction treatment and recovery workforce. Alaska is working to integrate peer supports into multiple environments as it is proven practice to boost recovery capital. Employment is an important part of recovery and this project will utilize Individual Placement and Supports to help the targeted population find employment of their choice. This project will provide recovery services to 195 clients in Year 1 and 212 clients in Year 2 (overall project total for treatment and recovery = 404). Workforce enhancement opportunities will be offered to 440 providers in Year 1 and 500 providers in Year 2 (overall project total for workforce development= 940). Overall individuals served as result of grant 1,344.
|1 H79 TI083325-01||
Alabama SOR is a statewide effort to reduce deaths related to opioid and stimulant overdose by 45% over the two-year project period. The project will continue to support efforts that have worked well in urban communities hardest hit by the epidemic, and expand the use of evidence-based practices and harm reduction strategies in rural communities that have limited resources to address growing substance use disorder problems. Project goals include: 1) lowering the opioid overdose death rate to 45% by 10/1/2022 by increasing the use of medication assisted treatment and evidence based treatment approaches to stimulant use; 2) lowering the opioid and stimulant overdose death rate by 45% by 10/1/2022 by reducing disparities in treatment and recovery support services accessibility; 3) expanding access to peer support services in targeted urban and rural communities; 4) improving data collection for opioid use disorders and stimulant use disorders, and using this data to enhance coordination of strategies and efforts across all state agencies in responding to this crisis; and 5) preventing new cases of opioid misuse by expanding community prevention efforts, including efforts that will increases the awareness of, and use of, naloxone. The project will implement five strategies to accomplish these goals: 1) expand access to Medication Assisted Treatment, particularly with populations, or in areas, where disparities in access exist or where opioid use disorders are most prevalent; 2) expand and enhance the use of telehealth technologies to increase access to substance use disorder treatment; 3) expand substance use prevention efforts that are consistent with the state’s Opioid Prevention Strategic Plan; 4) expand access to prevention, treatment and recovery activities for opioid use disorder (including illicit use of prescription opioids, heroin, fentanyl, and fentanyl analogs) and co-occurring conditions; and 5) expand access to prevention, treatment and recovery support services to address stimulant misuse and use disorders, including services for cocaine and methamphetamine use and co-occurring conditions. The project will serve 12,000 individuals annually and 24,000 throughout the two-year grant period. The project will be administered by the Alabama Department of Mental Health’s Division of Substance Abuse Services, which has been designated as the Single State Agency for SAMHSA SOR services.
|1 H79 TI083287-01||
The Arkansas Department of Human Services, Division of Aging, Adult & Behavioral Health Services will implement statewide programs to reduce opioid overdose-related deaths and unmet treatment needs for opioid use disorder (OUD) by increasing access to naloxone, medication-assisted treatment, and evidence-based prevention, treatment, and recovery support services to address OUD and stimulant use disorders, including cocaine and methamphetamine. Arkansas is a rural state comprised predominantly of Health Professional Shortage and Medically Underserved Areas that lack access to primary care and mental health services. The state is disproportionately impacted by abuse of illicit opioids and prescription drugs and poor access to treatment providers/facilities. Arkansas is a recipient of Prescription Drug/Opioid Overdose, State Targeted Response to the Opioid Crisis, and State Opioid Response grants. Treatment/prevention initiatives implemented with these grants were associated with decreased opioid prescription rates and overdose-related deaths and increase in naloxone administration. Programs to be provided will address service gaps, are potentially available to all Arkansans age 13 and older and will be implemented in accordance with National Standards on Culturally and Linguistically Appropriate Services. Healthcare provider and consumer education will be offered by University of Arkansas at Little Rock (UALR) MidSOUTH Center for Prevention & Training, University of Arkansas for Medical Sciences (UAMS) Reynolds Center on Aging, and the Arkansas Collegiate Network (ACN). MAT practitioner recruitment and training will be provided by UAMS MAT Recovery Initiative for Arkansas Rural Communities (MATRIARC) program. Naloxone distribution, community prevention activities, and law enforcement personnel training will be provided by the University of Arkansas Criminal Justice Institute. The Peers Achieving Collaborative Treatment (PACT) program will be enhanced by expansion into eight additional facilities and addition of certification testing and continuing education by the National Certification Commission for Addiction Professionals. National Association for Addiction Professionals memberships will be provided for Peer Recovery Specialists who successfully complete training. Grant funds will also be used to create a short-term residential substance abuse program at the Lewisville Juvenile Treatment Center and offer wraparound services/recovery assistance to Arkansas Community Corrections MAT participants (bus passes, transitional housing support, Family Counseling/Unification services, and Peer Recovery Specialist support). Sustainability of implemented programs is assured by documented success and cost effectiveness of Arkansas programs that have been, and will be, implemented with federal funding – e.g., 471 lives have been saved since the Arkansas PDO Project began in 2016 and the PACT program reduced recidivism in participants released into the community, with substantial taxpayer savings.
|1 H79 TI083314-01||
The American Samoa State Opioid Response (AS SOR) project through its five (5) goals will address the need for treatment, recovery and prevention services for individuals with an Opioid Use Disorder and stimulant abuse. The five goals are basically to increase capacity to screen, increasing access to treatment services for at-risk populations, strengthening the healthcare providers capacity to offer Medication Assisted Treatment, reduce high-risk behaviors that could lead to opioid abuse/misuse, and development of recovery support services in the territory. The AS SOR proposes to use this funding to help strengthen the capacity throughout the service delivery system to be prepared and equipped with how to treat and prevent an OUD.
|1 H79 TI083320-01||
The overarching goal of the Arizona State Opioid Response project is to increase access to MAT treatment, coordinated and integrated care, OUD/stimulant use disorder recovery support services and prevention activities to reduce the prevalence of OUDs, stimulant use disorder and opioid-related overdose deaths. The project approach includes developing and supporting state, regional, and local level collaborations and service enhancements to develop and implement best practices to comprehensively address the full continuum of care related to opioid misuse, abuse and dependency. The proposed activities within the Arizona Opioid State Opioid Response project will work synergistically with existing efforts to reduce stimulant use disorder, OUDs and opioid-related deaths by: (1) sustaining and enhancing naloxone distribution; (2) increasing localized community prevention efforts; (3) expanding navigation and access to MAT through 24/7 OTPs, Medication Units and extended hours OTPs; and (5) expanding access to recovery support services including housing, peer supports and supportive recovery programming. Measurable objectives to reduce stimulant use disorder, OUDs and opioid-related deaths will include: number of naloxone kits disseminated; MAT utilization and retention; use of the CSPMP; rates of opioid prescribing; rates of individuals in prescribed doses in excess of 50 MEDDs; community knowledge and prevention behavior; ED utilization; and rates of fatal and non-fatal overdose. Target population will, at minimum, serve: individuals re-entering the community from correctional settings; individuals in rural and isolated areas; individuals experiencing homelessness; tribal populations; veterans, military service members and military families; pregnant women and parents with OUD; individuals with physical disabilities and individuals who have experienced trauma, toxic stress or adverse childhood experiences (ACEs). The project will serve 250,000 unduplicated individuals between year one and year two under prevention activities and serve 7,908 unduplicated individuals with treatment and recovery services in year one and an additional 11,863 unduplicated individuals in year two, for a total project reach of 19,771 unduplicated individuals.
|1 H79 TI083285-01||
California will continue efforts under the MAT Expansion Project in SOR 2, while implementing and expanding evidence-based treatment for opioid use (OUD) and methamphetamine use disorders. Priority populations include American Indian and Alaskan Natives (AI/AN), youth, and OUD clients experiencing homelessness. An estimated 10,000 under or uninsured clients will be directly served and 300,000 will be impacted through prevention and education. In 2018, California's age adjusted opioid overdose rate per 100,000 residents was 5.82 with a statewide total of 2,428 deaths. California has experienced a rapid rise in fentanyl-related overdose deaths, nearly doubling from 431 deaths in 2017 to 786 in 2018. California's amphetamine overdose rate is identical to the rate of opioid overdose deaths in California in 2018, as compared to 2,428 opioid overdose-related deaths. SOR 2 projects and activities will be across the State with an emphasis on areas with the highest rate and volume of overdose deaths. Activities will focus on where individuals with substance use disorders (SUD) routinely present, such as primary care, hospitals, SUD treatment providers, and justice-involved settings. If the entity is responsible for health care of the SOR client, this project will help that entity expand access to care but if not, effectively refer/engage the client to treatment services. While access to MAT is a concern in rural areas of the State, many urban areas still lack capacity to treat all individuals with an OUD. Effective education for the justice-involved system, courts, child welfare, health system, workforce and SUD providers continues to be an effective method to combat stigma and engage clients into services. California will expand its approach to SUD prevention, treatment, and recovery services through the following objectives: 1) Develop additional MAT locations through strategic access points, such as health care providers including Tribal clinics, as well as hospital emergency departments and county jails; 2) Provide MAT services, prevention and recovery services to specific populations, such as AI/AN populations, youth and OUD clients experiencing homelessness 3) Expand overdose prevention activities to prevent opioid and methamphetamine overdose deaths; and 4) Expand access to evidence-based treatment for methamphetamine use disorder including direct service provision, contingency management training and prevention activities. California's SOR 2 projects will use evidence-based practices, including FDA-approved medications, counseling, peer support, and contingency management for methamphetamine use disorder. DHCS will work with county governments, health providers, community organizations, foundations and other key partners as part of a collaborative effort. The grant will continue to focus on reducing stigma, coordination of funding streams, creating project sustainability and increasing awareness of the effectiveness and availability of treatment for SUD.
|1 H79 TI083308-01||
The Colorado Department of Human Services, Office of Behavioral Health (OBH) proposes to address gaps in prevention, treatment and recovery services for opiate use disorders (OUD) through expansion of medication-assisted treatment (MAT); crisis and emergency services; naloxone distribution; residential treatment; sober living; peer supports; media campaigns; jail-based MAT and coordination with the criminal justice system. OBH estimates that nearly 44,000 individuals over the age of 18 are in need of treatment for OUD in Colorado, and existing services are unable to meet this need. This project will focus on these high-need populations, who face significant barriers: 1) uninsured/underinsured persons seeking MAT; 2) family members and children of individuals with OUD; 3) persons reentering the community from incarceration; 4) persons who interact with the emergency departments and the state crisis services; 5) persons with OUD who have infections from injecting drugs; and 6) high-utilizers of the criminal justice or emergency department services with unstable housing. Treatment data show the populations of focus are most likely to be 25-44, with males having a higher prevalence of heroin and no gender gap for prescription misuse. Less than 4% identify as LGBT, approximately 80% are White, and Hispanic populations represent 38% of the underinsured. Rural areas have the greatest gaps in care, especially west of the Rocky Mountains, while urban ares have the highest population in need of services. Identified gaps include access to affordable MAT and residential treatment, knowledge of naloxone and other resources to prevent overdose, connection to treatment following crisis, lack of family resources, gaps between the justice system and substance use disorder treatment, and access in tribal communities. Evidence-based strategies for addressing gaps include MAT funding for low-income uninsured patients; trainings for hospitalists, substance use providers, law enforcement, and tribal providers; prevention counseling for families; expanded capacity of crisis services; and a communications plan to reduce stigma. Project goals include prevention of OUD and overdose death; building recovery capital and support recovery services, support treatment access and services for people with OUD and or stimulant use disorder; and Government Performance and Results Act (GPRA) data collection and analysis to continue to improve the state systems. Outcome data include number of people receiving family resources, treatment, residential and recovery services, number of naloxone kits distributed, rates of opioid use and related deaths, and number of GPRAs linked to MAT. Over two years, grant activity goals will be to provide referral, family, prevention, treatment and recovery services for 4,800 individuals in Year 1 and 5,018 in Year 2, while also screening 4,800 people for HIV and viral hepatitis in each year of the grant. All together Colorado plans to serve 19,418 individuals across the life of the grant.
|1 H79 TI083299-01||
The Connecticut Department of Mental Health and Addiction Services (DMHAS), in partnership with numerous State and community-based organizations, proposes to continue a series of targeted responses intended to reduce the negative impact of opioid use on Connecticut citizens and communities. These responses build on the State's evolving recovery-oriented system of care, helping to continue to shift the focus of care from responding to acute episodes to a prevention and recovery management framework. Connecticut's strategy spans community education and grassroots prevention coalitions, to pre-recovery outreach and engagement, to recovery initiation through active treatment and recovery supports services, and finally, to long-term recovery maintenance. Connecticut's goals and objectives are designed to assist a population in cities and rural areas, who are actively using opioids, are early in recovery, and may have criminal justice involvement. These goals include: - Reduction of opioid overdose deaths and increase of awareness of the danger of opioid use using multi-faceted prevention strategies. These strategies are designed to reach all 3,588,184 of the State's citizens. - Increasing and maintaining access to treatment, with a focus on medication assisted interventions, for at-risk populations, including individuals involved in the criminal justice system. 1650 individuals are anticipate to receive treatment services, with 825 per project year. - Outreach and engagement to those individuals who are actively using opioids and not yet receiving treatment including individuals who may have been brought to the emergency department due to an opioid overdose. 7,950 individuals are expected to be reached out to, or 3,975 per project year. - Provision of recovery support for those newly in recovery, including temporary housing, utilizing peer specialists and employment support for individuals in methadone clinics, court involved, or otherwise in need to support in order to progress in their recovery. 1,950 individuals are projected to be in need of recovery support services per year for a project total of 3,900. Connecticut maintains considerable momentum to implement these projects. Community awareness of opioid problems has galvanized local, grass-roots groups into action Community coalitions including local government leaders, health professionals, educators, police, and behavioral health experts have formed to address this epidemic. The legislatively mandated Connecticut Alcohol and Drug Policy Council (ADPC) continues to support recommendations developed by subcommittees in the areas of Prevention, Treatment, Recovery, and Criminal Justice. Numerous proposed SOR projects area result of the Council's work. These new SAMHSA resources are crucial in order to support and implement the hard work of these groups.
|1 H79 TI083311-01||
The District of Columbia's Opioid Response 2 (DCOR 2) initiative will focus on increasing access to medication-assisted treatment (MAT), reducing unmet treatment needs, and reducing opioid overdose-related deaths through the provision of prevention, treatment, and recovery support services (RSS) to individuals with opioid use disorder (OUD). Expanded services and supports will also be provided to individuals with stimulant use disorders (STUD). Through support from the first State Opioid Response (SOR) grant (DCOR 1), the District has increased access to MAT, including in the DC Jail, and has expanded the array of substance use disorder (SUD) treatment and RSS. The SOR 2 grant will continue many of these initiatives, but will increase entry points into the system of care (e.g., mobile screening and MAT in high need communities) and better coordinate care as individuals move through the system by supporting the development of a care management entity and care managers at the DC Jail. Care managers will guide individuals through assessment, stabilization, and a coordinated network of services and supports. Peer support specialists will be used throughout the continuum of care to foster engagement and service connection. Training, technical assistance, coaching, and consultation will be available to SUD providers/health care professionals to increase their ability to address client needs. In addition, the District will implement a coordinated approach at the community level by facilitating key stakeholders in each ward to work collaboratively around prevention, community outreach, and education initiatives. The DCOR 2 initiative will be implemented in all eight Wards with particular focus on Wards 5, 7 and 8 (highest opioid fatalities). A revised LIVE.LONG.DC, the District of Columbia Strategic Plan to Reduce Opioid Use, Misuse, and Related Deaths will be a guide for accomplishing the work. The specific goals of the grant are to continue to implement the city-wide opioid strategic plan; ensure timely access to high-quality (consistent with the criteria of the American Society of Addiction Medicine), coordinated, co-occurring (substance use disorder and mental health) treatment and recovery-oriented system of care; educate District residents and key stakeholders on the risk of opioid use disorders and stimulant addiction and effective prevention and treatment strategies; engage helping professionals and organizations in the prevention, early intervention and treatment of substance use disorder treatment through workforce development; support the awareness and availability of, and access to, harm reduction services in the District of Columbia consistent with evolving best and promising practices; implement a shared vision between the justice and public health agencies to address the needs of individuals who come in contact with the criminal justice system; and prepare for program sustainability through evaluation, planning, and performance monitoring and training and implement a continuous quality improvement process. The DCOR 2 initiative will serve 2,000 unduplicated individuals over the life of the grant (1,000 in Year 1 and 1,000 in Year 2).
|1 H79 TI083305-01||
The Delaware State Opioid Response (SOR) Grant will strengthen and create sustainable change to address the full continuum of care, from prevention through treatment and recovery, by intensifying and deepening efforts to enhance and develop its system of care and adding additional supports. In FY18, the Delaware Division of Substance Abuse and Mental Health (DSAMH) began to address care, access, and treatment gaps through the Substance Use Treatment and Recovery Transformation (START) learning collaborative and the use of the Delaware Treatment and Referral Network (DTRN), a bidirectional referral platform. The project proposal's goals and objectives align with SAMHSA's Strategic Prevention Framework and the Institute of Medicine's Continuum of Care Model, as well as with the START initiative and strategic drivers: 1) Engaging and stabilizing people with behavioral health needs wherever they might be ready to engage, 2) Improving coordination across referrals and transitions, 3) Providing seamless access to care management and social needs that supports mental, physical, social and spiritual well-being, 4) Providing person-centered, peer-supported, long-term treatment support for patients and families in the community, and 5) Building prepared and resilient communities. SOR 2020 funding will support treatment and care improvements statewide, with a focus on the criminal justice population, transition-age youth, pregnant women and families, and populations with a disparate burden of substance use disorder (SUD) and co-occurring mental illness. The aims of the present proposal are to: 1) Continue to build the medication-assisted treatment (MAT) and stimulation use disorder (STUD) treatment capacity, 2) Build additional referral pipelines and "front doors" to treatment, including primary care, 3) Enhance existing treatment and wraparound services and implement new supports specifically for families and transition-age youth, and 4) Strengthen the prevention infrastructure. Enhanced data collection and analysis capabilities will be utilized to understand and refine these efforts in real time. To meet the above goals of this proposal, DSAMH and its project partners will implement a number of evidence-based strategies, including: crisis stabilization, telehealth, virtual social support and engagement, wraparound services to include peer recovery specialists and other services, MAT in emergency departments, behavioral healthcare integration, supports for transition-age youth, education and training around MAT and STUD treatment, supported employment, and parenting and education support. DSAMH proposes serving a total of 2,500 unduplicated clients each year, for a total of 5,000 over two years. This funding will allow Delaware to build sustainable capacity and infrastructure that improves treatment and services in the state after the funding ends.
|1 H79 TI083303-01||
Florida's State Opioid Response Project will implement a comprehensive approach to address opioid use disorders, stimulant use disorder, as well as opioid and stimulant misuse. An estimated 15,000 individuals will be served in each of the two grant years (for a total of 30,000 over the project period) through treatment and recovery services. A major objective of the project is to increase access to the most effective treatments for opioid and stimulant use disorders, including increased admissions to buprenorphine and methadone maintenance treatment and implementation of contingency management models. The population of focus for this project are uninsured and underinsured individuals who misuse opioids or stimulants, and individuals diagnosed with an opioid or stimulant use disorder. This includes individuals with co-occurring mental health conditions. The SOR-funded service array is comprehensive and covers the entire spectrum of care across prevention, treatment, and recovery support domains. The use of telehealth will be expanded to rural and underserved areas. The project will expand the distribution of naloxone (80,000 kits each year) and overdose recognition and response training through the Department's Overdose Prevention Program. To prevent opioid and stimulant misuse, there will be expanded implementation of evidence-based prevention programs with a target to reach 20,000 youth annually. Access to recovery housing will be expanded with a goal to establish 60 additional Oxford Houses. Training will be provided on Integrated Harm Reduction Psychotherapy, contingency management, and the community reinforcement approach. Additionally. SOR funds will be used to implement Recovery Community Organizations with training and technical assistance by Faces and Voices for Recovery. The project will also deploy Recovery Quality Improvement Specialists to conduct quality assurance reviews around recovery-oriented practices and Behavioral Health Consultants to support child welfare professionals in identifying substance use disorders and providing referrals for services.
|1 H79 TI083302-01||
The intend of the project is to establish a prevention, treatment and recovery for OUD. Evidence based that we will be using is a culturally appropriate one specifically called the "Pathways to Change". Three goals to address are as follows: (1) Build Capacity and infrastructure for data driven opioid use prevention, treatment and recovery at each of the FSM States: Chuuk, Kosrae, Pohnpei and Yap; (2) Reduce the onset and/or progression of opioid use and abuse of other illicit drugs and pathway drugs; (3) Reduce perceived acceptability of opioid use and other drugs use among the youth and the adult population.
|1 H79 TI083292-01||
Building on the current infrastructure, the prevention, treatment and recovery services implemented through the current Georgia State Opioid Response (SOR), the new SOR grant project will expand the continuum of prevention, treatment and recovery treatment oriented services in high need areas of the state that have providers with capacity and expertise related to OUD. Medication Assisted Treatment (MAT) will continued to be implemented in other areas of Georgia not currently covered by the current SOR grant project. It is important to point out that Georgia does not plan to allocate funds specifically for stimulants as we are mainly focused on MAT since we don't have state infrastructure separately for the treatment of stimulants specific. However, people with stimulants issue will receive treatment base on assessments and primary diagnosis by provider. The prevention services will build on activities that have been implemented as part of the current SOR project and add new ones where possible.
|1 H79 TI083331-01||
The Guam Opioid Response Project (GORP) is designed to increase access to substance use treatment, recovery support services and prevention activities to reduce the prevalence of Substance Use Disorders and Opioid Use Disorders amongst our young adult population ages 18-25. GORP intends to develop and implement a treatment program designed for young adults. The SOR funding will support the treatment of 25 participants in the first year of funding and 50 participants in the second year of funding. If the project continues to increase participation of young adults to the program, other local and federal funding will support the efforts of the project. Guam Opioid Response Project will also launch a Substance Abuse Prevention Campaign that will focus primarily on Youth ages 12 -17. This Youth Campaign will focus on increasing the capacity of the local middle and high schools, to reduce high risk behaviors of students that may contribute to substance abuse, to include tobacco use and vaping. Measurable prevention objectives to reduce OUDs and opioid-related deaths will include: increasing community knowledge and awareness through trainings and evidence-based programs and practice; and increasing access to Screening, Brief Intervention and Referral to Treatment (SBIRT). Measurable treatment objectives to reduce OUDs and opioid-related deaths will include: stigma reduction and knowledge of Medication Assisted Treatment (MAT); and increasing access to peer support services. Target populations will include young adults ages 18-26 with a Opioid Use Disorder (OUDs) and/or Substance Use Disorders (SUDs) and youth ages 12-17 in local middle and high schools.
|1 H79 TI083293-01||
Hawaii State Opioid Response (HI-SOR) The Hawaii Opioid Initiative (HOI)-A Statewide Response for Opioid and Other Substance Misuse. The HOI is an initiative launched throughout the state with the primary goal of addressing opioid and other substance misuse issues. The plan serves as a roadmap for a focused and sustainable response to opioid and other substances misuse in Hawaii. The HOI supports three primary themes: Theme 1: System Improvement Through Collaborative Response-identify and foster key systems-level coordination to positively impact statewide policy; Theme 2: Balanced Public Health/Public Safety Approach-identify and foster key systems-level coordination to balance public health with public safety needs; Theme 3: Healthcare Integration-ensure that Hawaii's healthcare system continues to develop as an integrated system that serves Hawaii's people with continuity along the behavioral and primary care spectrum. The Hawaii Opioid Initiative Framework consists of the following Workgroups and Committees: Executive Steering Committee (ESC): provides executive-level support and input on policy and program initiatives; Operational Workgroup (OWG): consists of chairpersons of the individual working groups who meet regularly to process and synthesize information, analyze findings, and create recommendations for a multi-systemic proposal; Workgroups 1-7 (WG): made up of more than 150 stakeholders with relevant expertise from various fields. Each WG contributes to and coordinates the goals and objectives of seven focus areas: 1) increased access to treatment; 2) prescriber education and pain management practices; 3) data-informed decision making; 4) prevention and public education; 5) pharmacy-based interventions; 6) support law enforcement and first responders; 7) screening, brief intervention and referral to treatment (SBIRT). Activities of the Hawaii Opioid Initiative will result in expanded access to substance use disorder (SUD) treatment and recovery support services to more than 200 individuals, annually; 400 individuals over the grant period. With improved implementation of telehealth, the State will increase access to SUD treatment and recovery support services in rural areas in the state such as Hana, Maui; Lanai; Kauai; and rural areas of Hawaii Island. Prevention education and public awareness will broaden with expanded use of social media. Additionally, with enhancements to the State's PDMP, prescriber alerts for multiple metrics will become available for the reduction of opioid and other pain medication prescriptions. This project exemplifies how system-wide success is achievable and sustainable through integration and collaboration of resources, organizations and activities.
|1 H79 TI083301-01||
To ensure SAMHSA's State Opioid Response (SOR) funding supplements current efforts and has the greatest impact possible, Iowa will coordinate, continue, and add to the efforts started with the State Targeted Response and State Opioid Response grants, as well as address emerging priorities across the state. Of particular relevance to Iowa, will be the inclusion of service eligibility for patients with stimulant use disorder (including methamphetamine). Iowa estimates that 1,300 Iowans will be served with treatment and/or recovery support services during the two years of this SOR funding with an additional 1,300 people receiving educational training. The focus of this project is to increase community capacity for a successful local response to the opioid and stimulant crises through the following goals: Goal 1: Iowans, statewide, can access quality treatment and recovery services for opioid and stimulant use disorders. Goal 2: Increase awareness of opioid and stimulant risks through statewide prevention efforts. The SOR Iowa project will leverage the service improvements gained through other opioid grants, making these services more accessible to Iowans affected by opioids and stimulants.
|1 H79 TI083282-01||
The State Opioid Response (SOR) funding will enhance the Idaho's Response to the Opioid Crisis (IROC) program. IROC provides Opiate Use Disorder (OUD) treatment and recovery support services, including Medication Assisted Treatment (MAT), to uninsured Idahoan's with an OUD that have an income under 200% of the Federal Poverty Level (FPL) and do not qualify for Medicaid. Idaho will 1) Coordinate statewide efforts to fight the opioid and stimulant crisis; 2) Promote and support the delivery of OUD and stimulant use disorder services; 3) Expand access to treatment, especially in rural and frontier communities; 4) Provide community-based recovery support services; 5) Disseminate materials to educate the public on the dangers of opiates and stimulants; 8) Expand opioid programs to include stimulant use disorder; 9) Collaborate with the five federally recognized Tribes in Idaho to address the individual needs of their communities; Idaho's goals and objectives are to: 1) Increase access to OUD services for eligible participants. Community-based providers will deliver treatment services to 500 individuals during year 1 and 2 for a total of 1,000. Live ECHO sessions pertaining to OUD and stimulant use disorder will be presented to a minimum of two hundred (200) treatment providers. Increase the number of OTPS in Idaho by two (2) each grant year for a total of four (4). Increase the number of OBOTS providing services in rural areas by one (1) each year for a total of two (2). Establish an active partnership with a national recovery housing organization for the creation of state-wide recovery housing standards and certification. 2) Promote recovery and resilience. At least 70% of project participants will report being socially connected after six (6) months of admission to the project. At least 60% of participants will report abstinence from alcohol or illegal drugs in the past thirty (30) days after six (6) months of entry into the project. At least 75% of participants will report no arrests in the past thirty (30) days after six (6) months of entry into the project. 3) Reduce the number of opiate and stimulant related deaths. The Office of Drug Policy will disseminate 5,000 Naloxone kits during year 1 and 5,000 during year 2 for a total of 10,000 Idaho will disseminate educational and resource materials regarding stimulant use disorder, OUD and MAT to stakeholders throughout the state. 4) Develop a collaborative approach to providing services and supports. The Project Coordinator will work with community law enforcement to implement LEAD programs in north and east Idaho by the end of year 1. At least 60% of participants will avoid readmission to ED settings within twelve (12) months of entry into the project. The LEAD, ED Warm Handoff, and HOPE projects will be expanded to individuals with stimulant use disorder within six (6) months of project start date. Funding will be available to the tribes within sixty (60) days of project start date. Two (2) recovery coach trainings will occur in five (5) of Idaho's seven (7) regions in both year 1 and 2 for a total of ten (10).
|1 H79 TI083278-01||
The Illinois Department of Human Services, Division of Substance Use Prevention and Recovery (IDHS/SUPR), submits this application in response to SAMHSA FOA # TI-20-012, SOR-II. Through this SOR-II grant, IDHS/SUPR will provide a comprehensive array of SUD evidence-based prevention, treatment and recovery support services that build upon the knowledge and learnings gained through the 2017 STR Grant, and the 2018 SOR-I Grant. Evidence of the multiple impacts of the opioid and stimulant crisis among Illinois residents is provided: increased primary opioid clients among IDHS/SUPR-funded treatment admissions, increased need for medication assisted treatment (MAT) for persons with opioid use disorder (OUD), increasing numbers of opioid overdose deaths, increasing numbers of persons using methamphetamines and other stimulants, and increasing numbers of opioid-related overdose reversals. The services supported and expanded through this SOR-II grant include: certification training on the Community Reinforcement Approach combined with Contingency Management; community-based linkage and referral services provided by peer outreach workers; Methamphetamine evidence-based treatment; Regional SUD Leadership Centers to create a sustainable network of care; access to MAT Hub and Spoke services; hospital screening and warm hand-off services provided by hospital staff; integration and increased MAT services provided by Federally Qualified Health Centers; MAT integration within criminal justice-involved population; county jail-based screening and warm handoff; housing stabilization for persons with OUD; recovery support digital toolkit; enhanced treatment services for pregnant and postpartum women with OUD; recovery housing services for persons with OUD; increased support for Buprenorphine prescribers; and, expansion of the Illinois Opioid Helpline. The prevention services that are proposed include: Naloxone purchase, training, and distribution services in counties of high need, through OTPS, and in areas with opioid overdose spikes; enhancements to the Illinois Prescription Monitoring Program (PMP); Illinois prevention provider contracts to support implementation of the OUD-focused Generation Rx program for adolescents; and, expansion of our statewide opioid awareness campaign. A data collection plan is provided that describes data collection, management, analysis, and reporting in response to federal requirements. This includes administration of the SAMHSA/CSAT GPRA tool to our unduplicated count of at least 5,000 persons served over the two years of funding at admission, six-month follow-up, and at discharge from services. A process and outcome performance measurement plan will be implemented. The organizational experience, resources, and qualifications of IDHS/SUPR and our major partner organizations are described. Biographical sketches for the Illinois SSA, the Project Director, the Project Coordinator, and other grant staff are provided. A line-item budget and narrative justification is proposed for $36,764,508 for each of the two years of this SAMHSA funding opportunity.
|1 H79 TI083279-01||
Since the first day of Governor Eric Holcomb’s administration in 2017, he has called for an “all hands on deck” approach to the growing drug crisis in Indiana. The Holcomb administration has made addressing the drug crisis one of the pillars of his Next Level Agenda. As part of that agenda, Governor Holcomb appointed an Executive Director for Drug Prevention, Treatment and Enforcement, and supported legislation to create the Indiana Commission to Combat Drug Abuse (ICCDA). The Commission includes key members and stakeholders across state agencies and legislators. The Commission developed a strategic plan, and based on identified unmet needs, gaps and issues determined the geographic catchment area will encompass all ninety-two (92) counties within Indiana for several identified strategies. The population of focus has included individuals across the lifespan who have been diagnosed with an Opioid Use (OUD) with emphasis on: adult men and women who are uninsured or underinsured; pregnant women and/or women with children; adolescents; offenders re-entering the community; and veterans and their families. Feedback from stakeholders in the field as well as supporting data suggest that stimulant use has become increasingly problematic Indiana. According to Indiana State Health Department Overdose data, the number of deaths per year in Indiana from psychostimulants has risen 175% from 2016 to 2019. According to the Drug Enforcement Agency (DEA), while domestic methamphetamine production has decreased across the United States, Indiana remains among the nation’s leaders in meth lab and equipment seizures in 2018. Lastly, according to initial Government Performance and Review Act (GPRA) data from the State Opioid Response grant, 26% of people served for opioid use disorder also reported a stimulant or cocaine use disorder. During the State Opioid Response Two grant period Indiana seeks to address the continuing opioid epidemic with many of the existing goals from State Opioid Response, but also includes expanded consideration and strategies for people experiencing stimulant use disorder. Indiana will 1) Expand recovery housing for men, women, and women with children or pregnant with 42 additional Oxford Houses serving 500 additional people; 2) Expand the number of credentialed addiction service providers in Indiana by 50; 3) Increase access to medication for opioid use disorder for individuals with opioid use disorder by 75% or 504 people per year in Indiana; 4) Extend reach of prevention and education efforts to all 92 counties in Indiana; and 5) Increase collaboration between criminal justice and behavioral healthcare providers to 90% of counties in Indiana by end of the grant period.
|1 H79 TI083280-01||
This grant will provide access to medication-assisted treatment, to reduce unmet treatment needs, and to reduce overdose deaths for Kansans suffering with opioid/stimulant use disorders. Strategies and interventions will focus on evidence-based prevention, treatment and recovery support services. The focus will be on illicit use of prescription opioids, heroin, fentanyl and fentanyl analogs, as well as stimulants.
|1 H79 TI083283-01||
Guided by the Recovery-Oriented Systems of Care framework and the Kentucky Opioid Strategic Action Plan, the purpose of Kentucky's 2020 State Opioid Response (SOR) is to support the implementation of a comprehensive response to Kentucky's opioid and stimulant crisis by expanding access to a full continuum of evidence-based opioid and stimulant use disorder prevention, treatment, and recovery supports, especially in areas of the Commonwealth that are at increased risk. Although the number of drug overdose fatalities decreased by 15% from 2017 to 2018, the first decline in deaths since 2013, drug overdose deaths remain nearly 50% higher than the national average. Further, 75% of all drug overdose deaths in 2018 involved opioids, and rates of stimulant use are rising rapidly. Addressing this evolving epidemic is a top priority across all levels of government, public, and private partners. Central to this response is an infrastructure that builds a behavioral health system with the capacity to deliver high quality, evidence-based interventions in a data-driven manner. The goals of Kentucky's SOR grant are to: 1) Implement statewide opioid and stimulant use prevention education, opioid stewardship, and community-guided prevention efforts to decrease overdose deaths; 2) Increase the capacity of individuals and providers to reduce harms associated with opioid and stimulant use; 3) Increase utilization of evidence-based treatment models including access to FDA-approved Medications for Opioid Use Disorder (MOUD) and reducing unmet treatment need; 4) Expand community recovery support services to facilitate long-term recovery; and 5) Reduce the impact of opioid and stimulant use on children and families. Informed by Kentucky's data-driven Opioid Strategic Action Plan, populations of focus are overdose survivors; pregnant/parenting women with opioid use disorder (OUD) and/or stimulant use disorder (SUD); justice-involved individuals with OUD/SUD; children, transition-age youth, and families impacted by OUD/SUD; and persons with co-occurring OUD/SUD and mental health disorders. Kentucky proposes to serve 77,500 individuals in Year 1 and 110,500 in Year 2. Grant activities will be implemented in the following high-risk catchment areas identified by calculating an overdose composite risk index score (opioid-related rates of fatal overdose, emergency department visits, hospitalizations, and morphine milligram equivalencies greater than or equal to 100): greater Louisville, greater Lexington, Northern Kentucky, Eastern Kentucky, and selected counties in Western Kentucky. Through the 2020 SOR, Kentucky will be better equipped to support the behavioral health of the Commonwealth and implement evidence-based interventions that are necessary to end the opioid epidemic.
|1 H79 TI083324-01||
The Louisiana State Opioid Response (LaSOR) Project 2.0 will enhance existing statewide prevention, intervention, treatment, and recovery support services statewide for individuals with or at risk for opioid use disorder (OUD) or stimulant use/misuse (SUM).The priority populations to be served by this grant are: (1) the under- and uninsured, (2) the criminal justice population, (3) tribes, (4) pregnant women or women with infants experiencing neonatal opioid withdrawal symptoms, (5) people who inject drugs, (5) colleges and universities, and (6) school age children (for prevention). The goals of LaSOR 2.0 include: 1) Identify and address needs of state and federally-recognized tribes; 2) Decrease opioid and stimulant overdose death rates by increasing access to treatment services for the under- and uninsured with OUD or SUM; 3) Increase access to community recovery support services for patients with OUD or SUM; 4) Increase prevention, intervention, and education activities for opioid and stimulant use, misuse, and abuse; 5) Provide treatment transition and referral for patients reentering communities from criminal justice settings; and 6) Increase access to harm reduction strategies and linkage to HIV and viral hepatitis testing for priority populations. LaSOR 2.0 will provide a variety of services for 3,095 unduplicated individuals (1,355 in year one and 1,740 in year two). LaSOR 2.0 will expand and enhance the existing hub and spoke model, with Opioid Treatment Programs (OTPs) serving as hubs and Office Based Opioid Treatment (OBOT) providers serving as spokes. OBOT providers will receive support from Spoke Care Teams, education and consultation from Tulane University through academic detailing and Project ECHO, and psychiatric consults from Louisiana State University Health Sciences Center. In addition, the Mother-Baby Substance Exposure Initiative (MBSEI) will provide five birthing facilities with a patient navigator to connect identified women with treatment, resources, and providing social support as needed. Prevention and intervention strategies include education through the Prescription Drug Abuse Prevention Module of Life Skills Training, the Opioid Module of Project Alert and Generation Rx; safe storage and proper disposal of prescription medications; distribution of Narcan Kits to institutions of higher education, first responders, jails, and federally qualified health centers; faith based community partnerships; and a media campaign. OBH will host webinars and on-site trainings for healthcare professionals on opioid use, stimulant use and non-drug alternatives to pain management. In addition, peer trainings and webinars for institutions of higher education will be held. In addition, OUD in college students will be addressed through collegiate recovery programs and an evidence based substance use screening and assessment tool for university health centers. Community recovery support strategies include expansion of Oxford Houses statewide; Crisis Outreach Mobile Teams that will provide outreach services and mobile peer recovery services; placement of Peer Recovery Support Specialists in hospital emergency departments; and grief groups for families and loved ones who experienced a loss due to an opioid overdose. A pre-release opioid treatment program will be expanded in correction facilities to address OUD and SUM in the criminal justice population. In addition, Health Coordinators will be provided to Syringe Service Programs to expand harm reduction strategies and linkages to Hepatitis C and HIV testing. Finally, the needs of state and federally-recognized tribes will be identified through a thorough needs assessment and addressed through strategy implementation. This list of coordinated prevention, intervention, treatment, and recovery support services will increase Louisiana's capacity to address issues of opioid use across our state.
|1 H79 TI083328-01||
While the number of opioid-related overdose deaths in Massachusetts has declined an estimated 5% from its peak in 2016, indicating smalls sign of progress; Massachusetts stills loses almost 2,000 people per year to opioid overdose with a number of high-risk populations and communities still disproportionally impacted. According to preliminary data, there were 2,023 confirmed and estimated opioid-related overdose deaths in 2019. Additionally, in the first nine months of 2019, cocaine was present in approximately 45% of opioid-related overdose deaths. With SOR funding the Massachusetts Department of Public Health (DPH), the applicant organization, will serve individuals affected by the opioid crisis including individuals who use stimulants, specifically targeting these high risk populations: communities of color, individuals who have experienced a prior overdose, youth and families impacted by the opioid crisis, persons with history of incarceration, pregnant and parenting women, individuals experiencing homelessness, individuals at risk of contracting and/or currently living with infectious disease, people who use stimulants alone and/or with other drugs, and persons with co-occurring disorders. MA DPH will ensure that funds are directed at the most marginalized populations and address systemic racial and ethnic disparities in access to SUD services. We seek to serve 11,200 individuals annually over the two-year project period through implementing the following activities: 1) Prevention and intervention services for youth and families; 2) Overdose prevention and harm reduction services including Post Overdose Support Teams to outreach to people who have overdosed; 3) Opioid Treatment Program (OTP)/Office-Based Opioid Treatment (OBOT) enhancements to increase access for historically underserved populations; 4) Expansion of opioid treatment access initiatives such as Hub and Spoke/Collaborative and Transitional Models of Care; 5) Treatment and recovery support services for individuals with criminal justice involvement that includes MAT induction, treatment and recovery planning; 6) Programming targeting pregnant and parenting women and their families that includes wrap-around supports, peer recovery coaching, and access to MAT; 7) Recovery supports including recovery housing, rapid rehousing, and the Access to Recovery program which facilitates client choice by providing voucher-based options and life skills training to support recovery goals; and 8) Expansion of developmentally appropriate recovery supports for youth and young adults. We also propose to: 9) Enhancements to existing state data analysis and reporting capabilities and improvements to web-based platforms to disseminate timely and accurate information to address the opioid crisis; 10) Implementation of wide-spread workforce development capacity building and training activities targeting a variety of sectors and audiences; and 11) Development and expansion of strategic communication and media campaigns targeting high-risk populations and high-need geographic regions in the Commonwealth to increase knowledge about addiction, decrease stigma, and improve awareness on how to prevent overdose and how to access treatment and recovery supports. We anticipate the MA SOR grant activities will improve, expand, and enhance access to opioid and/or stimulant use disorder treatment, prevent overdose, and support sustained recovery to achieve life-saving results.
|1 H79 TI083330-01||
The proposed program, State of Maryland Opioid Response II (MD-SOR II) is designed to increase the capacity of local service delivery systems to provide coordinated and integrated evidence-based prevention, treatment and recovery services to individuals with substance and opioid use disorders. It will improve access and enhance services by reducing unmet treatment need, strengthening the workforce, engaging primary care providers in identifying harmful substance use, increasing access to treatment, and emphasize peer and other recovery support. The emphasis for MD-SOR II will be areas in which our data clearly reveals demonstrated need. In 2018, Maryland experienced an average of 6 opioid related deaths per day. Overdose deaths are more likely for individuals between the ages of 26-49 (54.6%), White (62.1%) and male (73.1%). Since 2017, deaths among African Americans have increased by 40%. The highest death rates are in Baltimore City (4 times the state rate) and three rural counties. Opioid prescriptions decreased 28% from 2017 to 2019. Cocaine and methamphetamine deaths increased 3 fold between 2015 and 2019. The Maryland Department of Health's Behavioral Health Administration (MD-BHA) worked with a variety of partners to seek input in determining the best use of the funding to maximize the impact for the population. MD-BHA has decided that our goals for the program are to increase access to Medication Assisted Treatment (MAT); reduce unmet treatment need; and reduce opioid related details through prevention, treatment and recovery using evidence-based practices. MD-BHA seeks to enhance public and provider awareness of causes and resources available for solutions; improve screening, intervention and referrals for treatment; create a welcoming array of services that are locally available through providers who utilize medication assisted treatment; increase the capacity to handle crises through crisis walk-in centers, crisis beds and safe stations; and provide individualized recovery services across the age spectrum with the assistance of peers and increased housing choices. As one of the first States to recognize the promise offered by Evidence Based Practices (EBP), we will maintain this emphasis on EBPs and quality utilizing a continuous quality improvement and a data-driven decision-making framework. Maryland is committed to a strategic approach to availability of quality services while reducing and eliminating opioid use. The MD-SOR II grant provides us with the opportunity to make a tremendous difference in individuals' lives. Numbers of individuals served each year and in total: Year 1 - 105,803, Year 2 - 117,209 and across the lifetime of the project is 223,012.
|1 H79 TI083304-01||
Maine’s StimSOR2020 grant application incorporates an array of services spanning treatment, recovery, and Primary and Community prevention strategies that target several at risk populations in the state. The flexibility to fund stimulant use treatment programming and community prevention interventions is embraced by the Department of Health and Human Services, as it increases the ability to positively impact the polysubstance use issues currently experienced in the State of Maine. Contained within this grant application are the following service proposals: • Funding for continued support of Re-entry Medication Assisted Treatment (MAT) programs currently across eight of Maine’s sixteen counties. To more comprehensively address the treatment needs of this population, there is an intent to implement Opioid Treatment Program (OTP) pilots in up to three county correctional facilities, as well as providing non-medication treatment options of Intensive Outpatient and Outpatient counseling programs. • Creation of a recovery supports pilot that will fund non-Medicaid reimbursed services for the pregnant and post-partum women that are enrolled in OUD treatment programming through the CMS Maternal Opioid Misuse cooperative agreement. • Expansion of recovery coach placement in emergency departments that offer Rapid Induction MAT. • Continuation of the Medication Assisted Recovery Program (MARP) in the City of Portland that is largely focused on the homeless individuals and stabilization through a treatment service package that includes MAT, case management, counseling, housing, and eventual transition to more traditional community treatment programming. • Primary prevention education to both youth and prevention providers that broadens to include a focus on stimulant use. • Implementation of community prevention programming that establishes both HIV and Hepatitis testing and applicable vaccines for at-risk populations, focusing on FQHC and Linkage to Care sites and aligning with the ME CDC’s Vulnerability Assessment areas of need. • Distribution of naloxone kits to Fire/Rescue first responder departments, that struggle to maintain a sufficient on-hand supply due to budgetary constraints. • Establishment of pilot sites for the provision of Contingency Management/Community Reinforcement Approach (CM/CRA) to better address stimulant use. DHHS will prioritize the following service recipients for reimbursement: • The uninsured population; eight percent of people in Maine that currently do not qualify for the state’s Medicaid program; and underinsured pregnant and parenting women, transient population homeless individuals, and those injecting drugs intravenously, which aligns with SATPBG priority populations.
|1 H79 TI083298-01||
The purpose of the Michigan State Opioid Response 2 project is to increase access to Medication Assisted Treatment using the three FDA approved medications, reduce unmet treatment needs, reduce overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder (OUD) and stimulant use disorders (StUD), and improve quality of treatment for StUD and OUD. Michigan aims to accomplish these goals with the following objectives: 1) improving the sate infrastructure for individuals with an OUD and StUD; 2) training PIHP and provider administration on infrastructure improvements, and training provider staff on evidence based interventions and fidelity measures; 3) implementing evidence based prevention and treatment interventions with accompanying fidelity instruments to ensure that the quality of the intervention is consistent across the provider network; 4) expanding overdose education to include harm reduction methodologies; 5) increasing supportive services to probationers and parolees and supporting diversion and specialty treatment courts; 6) implementing a service delivery model to stabilize OUD patients in a specialized treatment setting focused on the care and treatment of OUD and associated conditions such as mental and physical illness; 7) supporting the use of peers in medical and community; 8) increasing recovery housing and peer support services for individuals with OUD; and 9: disseminating a statewide media campaign for the purpose of public education and stigma reduction.
|1 H79 TI083289-01||
The Behavioral Health Division of the Minnesota Department of Human Services is the Single State Authority and proposes a comprehensive Minnesota State Opioid Response to the opioid crisis by increasing access to medication-assisted treatment, using three FDA-approved medications for the treatment of opioid use disorder; reducing unmet treatment need; and reducing opioid overdose related deaths through the provision of culturally responsive, evidence-based prevention, treatment, and recovery services for opioid use disorder, including illicit use of prescription opioids, heroin, and fentanyl and fentanyl analogs; stimulant misuse and use disorders, including cocaine and methamphetamine; and nicotine use disorder. The Minnesota State Opioid Response proposes to expedite culturally responsive, evidence-based prevention, treatment, and recovery services and resources for opioid use disorder, stimulant misuse and use disorders, and nicotine use disorder by coordinating and integrating those services and resources in every phase of the continuum of care. In 2018, the most recent year for which comparable data is available, Minnesota ranked first among all states and the District of Columbia with regard to the disparity rate ratio of drug overdose deaths among Native Americans relative to whites, and second among African Americans relative to whites. In 2018, Native Americans were six times more likely to die from a drug overdose, including from an opioid overdose, than whites; African Americans were two times more likely to die from a drug overdose than whites. The drug overdose mortality rate disparities in Minnesota have worsened since 2018. The Minnesota State Opioid Response recognizes the need to provide an immediate and effective response to the following populations of focus: American Indians; African Americans; and individuals with justice involvement. In addition, our state opioid response grant application includes pregnant and parenting women with opioid use disorder, because this group presents in significant numbers and is embedded in the populations of focus. Other populations with an unmet treatment need for opioid use disorder are the homeless and other populations of color. With SOR grant funding dollars Minnesota proposes to serve 25,675 of unduplicated individuals annually and 51,778 of unduplicated individuals over the time of the SOR project, thus the total of unduplicated individuals we propose to serve is 51,778.
|1 H79 TI083284-01||
The purpose of the Missouri State Opioid Response 2.0 (SOR 2.0) project is to build upon the system changes for Opioid Use Disorder (OUD) prevention, treatment, and recovery that have been activated by Missouri's State Targeted Response (STR) grant and first SOR grant, while adding a focus on stimulant use and adding critical initiatives. Upstream prevention approaches targeting substance misuse in high-risk youth and clinical decision making among medical providers will be key grant components. Overdose prevention and response strategies will be expanded to better reach active drug users through various efforts, including telemedicine visits, street outreach programs, and partnerships with a community-based anti-violence program. Through the continued and honed implementation of Missouri's "Medication First" treatment approach for OUD as well as Contingency Management for stimulant use, we aim to increase access to evidence-based treatment and improve transitions of care. By expanding peer-led recovery training, we aim to better prepare individuals with lived experience to deliver valuable clinical support services. To enhance the sustainability of project accomplishments, administration and evaluation teams will strengthen existing collaborations, help enact key system sustainability changes, and demonstrate the effectiveness of protocols implemented through the award. Missouri's primary focus will be increasing access to treatment for OUD and providing evidence-based services to individuals with presenting for care within state-funded programs, hospitals, and the St. Louis County Jail, the largest county jail in Missouri. Primary prevention activities will center on increased awareness of prescription drug misuse and healthy coping skills led by the Boys & Girls of America, Big Brothers Big Sisters, and local agencies in high-risk areas. Overdose prevention and naloxone training efforts will target active drug users and homeless individuals through street outreach programming and training social services staff. Grant partners will provide telemedicine and consultation to providers treating pain and OUD, and statewide telemedicine infrastructure for OUD treatment delivery will be further enhanced and include protocols for post-overdose buprenorphine inductions. Holistic recovery support services will be provided through Recovery Community Centers and Recovery Support Services, particularly housing, employment assistance, and family support, delivered with a focus on peer engagement and modification-friendly principles. The State of Missouri Department of Mental Health (DMH) will lead the project, with administration, implementation, and evaluation activities performed by the University of Missouri, St. Louis (UMSL) - Missouri Institute of Mental Health (MIMH). Missouri's SOR 2.0 project will further transform the system of care for OUD by implementing evidence-based protocols demonstrated to save lives, offering extensive multimodal professional training and consultation, and delivering effective and compassionate services to individuals across healthcare settings throughout the state.
|1 H79 TI083332-01||
This project aims to continue the work of the CNMI CHCC State Opioid Response Program.
|1 H79 TI083319-01||
Despite the prevalence of poverty, low reporting capacity, health disparities etc. Mississippi has made great strides in combating substance use disorders (SUDs), in a relatively short time frame. Supported by SAMHSA’s State Targeted Response (STR) and State Opioid Response (SOR), Mississippi has achieved the following outcomes: increased access to treatment; increased availability and decreased stigma of Medication Assisted Treatment (MAT); increased implementation of evidence-based treatment; increased public awareness; increased capacity for and availability of Narcan; increased partnerships and collaboration among state agencies and with community-based organizations; improved state-level infrastructure; and reduced duplication of services between public agencies. At the very onset of the MS STR/SOR Projects, a paradigm shift was past due among the State’s Community Level Service Providers and First Responders. Many providers were of the mindset that MAT was merely a substitute of one addiction for another one. This type of thinking promoted abstinence as the only true means of recovery. At the same time, many law enforcement agencies and emergency response entities were of a mindset that was reluctant to concepts that called for the administering of overdose reversal medications. This culture subscribed to a thought process that suggested that there is little need to waste time, effort and/or resources on addicts that were a drain on society and would likely die eventually from another overdose, a high-risk lifestyle or complication related to addiction. It was through SAMHSA’s STR/SOR that Mississippi was afforded education and awareness resources, such as Stand-Up-Mississippi, Town Hall Meetings and increased services, that our state began to gain leverage on the SUD Crisis. Efforts such as these will allow MS to further reduce OSUDs during 2020-2022. The 2020 MS-SOR/SOR II will take aim at the remaining challenges and gaps. Best practices during SOR II will reduce re-occurrence of service gaps. The proposed project will target an estimated 11,500 Mississippians through: (1) prevention of Opioid and/or Stimulant Use Disorders (OSUDs) for persons under 18; (2) treatment and recovery for adults with OSUDs; (3) infrastructure enhancements. The identified geographic catchment area will be the entire state. Community Mental Health Centers and free-standing prevention and treatment programs cover all 82 counties. Prevention services will target school-aged youth in grades 3-8. The treatment and recovery component will target adults over 18 with OSUDs. Funding made available by SOR II will supplement and not supplant existing opioid prevention, treatment, and recovery activities. Funding goals, objectives, and plans will be cross-referenced for duplication to include COVID-19-related funding (NOA received), the Substance Abuse Block Grant (SABG), state funding, and discretionary substance abuse prevention grants. DMH will utilize a competitive submission process whereby proposals are solicited, scored, and reviewed using a rating matrix developed directly from the requirements specified in the SAMHSA SOR 2020 FOA and further defined by DMH.
|1 H79 TI083306-01||
The Montana State Opioid Response (SOR II) Project will support the implementation of evidence-based prevention, treatment, and recovery support strategies for individuals with Opioid and/or Stimulant Use Disorders (OUD and SUD) in Montana, with an emphasis on American Indians and individuals involved in the criminal justice system. American Indians are Montana's largest racial minority and face a more than 20-year disparity in life expectancy compared to white Montanans, partially attributable to higher rates of substance use. Justice system involvement for individuals with OUD and SUD is on the rise in Montana with an estimated 90% of the individuals in Montana jails being held for substance-abuse related offenses. Key strategies funded under this application include support for a comprehensive OUD treatment model at 16 provider locations in MT and providing technical assistance and training related to peer support, DATA Waivers, implementing MAT in justice system facilities, naloxone use, and the PAX Good Behavior Game. The goals and objectives for the MT SOR II projects are: Goal 1: Increase access to evidence-based treatment for underserved populations with OUD and SUD in Montana. Objective 1.1: By 8/31/2022, 1300 Montanans in clinically underserved group s will receive comprehensive OUD treatment services, including MAT, care coordination, behavioral health and peer support services, and HIV and Viral Hepatitis C testing. Objective 1.2: By 8/31/2022, 150 Montanans with methamphetamine or other stimulant use disorder will receive treatment services including contingency management, community reinforcement, and/or peer support. Objective 1.3: By 8/31/2022, a minimum of three detention centers will provide MAT and/or treatment transition services to individuals in or discharging from jail. Goal 2: Increase access to evidence-based prevention and recovery services for OUD and SUD in Montana. Objective 2.1: by 8/31/2022, 3500 naloxone units will be distributed to key partners including trained peer support specialists, First Responders, and Syringe Exchange Programs. By 8/31/2022, 50% of Montana grade schools will be trained to implement the PAX Good Behavior Game. Objective 2.3: By 8/31/2022, Montana will adopt standards, policies, and procedures to promote quality Recovery Housing. Goal 3: Enhance collaborations to increase the reach and impact of SOR activities statewide. Objective 3.1: By 8/31/2022, SOR leadership will meet four times with tribal health leaders to ensure effective coordination and appropriate implementation of SOR activities for Montana's American Indian population. Objective 3.2: By 8/31/2022, Montana will have a health communication plan to deliver evidence-based prevention and recovery messages to underserved populations. We plan to serve 1,450 unduplicated individuals throughout the two-year cycle; 700 in year one and 750 in year two. At this time, we expect to begin providing direct services by the third month after the grant is awarded.
|1 H79 TI083312-01||
The primary purpose of the proposed project is to design and implement a plan to further address the opioid crisis, founded on North Carolina's Opioid Action Plan 2.0, launched June 2019. The Action Plan aims to prevent, reduce harm and connect to care while focusing on several key areas: (1) Reduce the supply of inappropriate prescriptions and illicit opioids; (2) Prevent future opioid addiction by supporting children and families; (3) Advance harm reduction; (4) Address non-medical drivers of health and eliminate stigma; (5) Address the needs of justice-involved populations; (6) Expand access to treatment and recovery supports, and; (7) Track progress and measure impact. The focus of these SOR 2 funds will be on activities that can realistically be accomplished within the time frame of the grant. Additionally funding has been set aside in the budget to address individuals with or at risk of stimulant use disorder.
|1 H79 TI083323-01||
The purpose of North Dakota's SOR grant is to address the opioid crisis by increasing access to MAT, reduce unmet treatment need and reduce opioid overdose-related deaths through the provision of prevention, treatment and recovery activities. The state also intends to address stimulant misuse and use disorders through the provision of evidence-based prevention, treatment and recovery support services. Overdose deaths in North Dakota have increased from 20 deaths in 2013 to 77 deaths in 2016, then saw a decrease in 2017 of 68 according to the CDC/NCHA National Vital Statistics System, Mortality. The three OTPs in the state are serving 776 individuals as of May 1, 2020. A quarter (27.9%) of drug types seized in drug and narcotic violations in the state are stimulants (Crime in ND, 2018). According to the 2017-2018 NSDUH, 2.07% of North Dakotans ages 18-25 and 0.9% of North Dakotans ages 26 and older reported methamphetamine use in the past year. The first goal of ND's SOR grant is to decrease use/misuse of stimulants and opioids through the implementation of evidence-based primary prevention strategies. The following summarized objective was identified to achieve this goal: (1) implement Parents Lead and Opioids: Fill with Care campaign messages. The second goal is to prevent opioid overdose-related deaths by increasing implementation of evidence-based prevention strategies. The following, summarized objectives were identified to achieve this goal: (1) messaging related to evidence-based strategies to prevent opioid-overdose deaths; (2) increase the general public's access to naloxone. The third goal is to increase comprehensive evidence-based treatment and recovery services to support positive outcomes for individuals with an OUD and/or stimulant use disorder. The following summarized objectives were identified to achieve this goal: (1) implement comprehensive care coordination and recovery support services; (2) reduce barriers to treatment. Considering all goals and objectives above, the entire state population (755,393) has the potential to be reached throughout the grant period. This is mostly due to activities implemented to support the first and second goals. Because the state does not have a well-represented number for how many individuals have an OUD or stimulant use disorder, it is roughly estimated that 800 individuals will be served over the two-year grant period. Evaluation data will be collected to answer the evaluation questions posed in the FOA.
|1 H79 TI083322-01||
The purpose of Nebraska's State Opioid Response program is to substantially reduce the incidence of misuse of prescription opioids and reduce the use of illicit opioid and stimulant drugs in Nebraska through ongoing collaboration between practitioners, experts and leaders across the continuum of care. The program will also work to mitigate the effects of opioid use disorders (OUD), including both prescription opioids and illicit drugs, such as heroin, by identifying statewide needs, increasing access to treatment, including Medication Assisted Treatment (MAT), and reducing prescription drug overdose and stimulant use deaths through the provision of prevention, treatment and recovery activities. The Division of Behavioral Health (DBH) intends to serve 100 individuals in Year 1 of the grant and 120 individuals in Year 2. DBH will partner with other agencies to provide services to underserved populations statewide without duplicating efforts. Nebraska's goals include: assessing state and tribal opioid needs; implementing prevention initiatives including, opioid prescribing guidelines, opioid and stimulant awareness media campaigns, safe drug disposal initiatives, funding community coalitions to provide OUD and stimulant use prevention EBPs in communities of need, and provide Naloxone to at risk populations and providers; implementing clinically appropriate evidence-based practices (EBPs) for OUD and stimulant use treatment including training providers in the ECHO model, funding access to Naloxone, enhancing the utilization of MAT through the funding of Buprenorphine and providing training opportunities to the peer support curriculum specific to opioids and stimulants; and providing assistance to patients with treatment costs by providing funding for Buprenorphine. DBH intends to serve the entire population of the state through training and prevention initiatives, while targeting high burden areas of the state for outreach, training and technical assistance.
|1 H79 TI083326-01||
NH Department of Human Services seeks this grant to strengthen and expand a comprehensive approach to address NH's opioid and substance use disorder epidemic through various prevention, treatment, and recovery services. NH intends to increase services for individuals with OUD/SUD statewide and to include stimulant misuse. While services will be made available to anyone seeking assistance in NH, special populations will be made a priority for some of the program designs including children and young adults, pregnant women, Veteran and service members, individuals with or at-risk for HIV/AIDS, older adults caring for a minor child due to DCYF involvement, and justice involved individuals and those re-entering the community post incarceration.
|1 H79 TI083317-01||
The goal of the New Jersey State Opioid Response (NJ-SOR) is to address the opioid crisis confronting the state using a variety of strategies. The key objectives are to increase access to medication assisted treatment (MAT), reduce unmet treatment need and reduce opioid related deaths. To address these objectives, the New Jersey Division of Mental Health and Addiction Services (DMHAS) will develop infrastructure support to provide buprenorphine in standard outpatient and intensive outpatient substance use disorder (SUD) treatment as well as a low-threshold buprenorphine induction program. A new mobile van pilot program will be developed to facilitate low induction medication, case management and other ancillary services for individuals with an opioid use disorder (OUD) in communities with low access to MAT and high rates of homelessness. Additionally, a program will be developed to enhance overall recovery in stimulant use disorders utilizing contingency management. A public information, education, and training campaign will be launched to reduce discrimination and promote MAT as the evidence-based practice (EBP) for OUD. Additionally, opportunities for training, professional development and wellness services will be developed for OUD treatment professionals, as well as, recovery service workers. Prevention efforts will include expanding the target groups that receive naloxone training and kits through the Robert Wood Johnson Medical School and Opioid Overdose Prevention Program (OOPP), as well as, expanding the availability of naloxone kits to high risk populations through partnerships with New Jersey's seven Harm Reduction Centers and statewide distribution events. Recovery activities will include a continuation of the Opioid Overdose Recovery Programs (OORP) and the Support Team for Addiction Recovery programs (STAR). Anticipated outcomes of the SOR include: reduction/abstinence from drugs and alcohol, increase in employment, reduced criminal justice involvement, increased social connectedness, and increased percentage of individuals completing treatment at the recommended level of care. Additional outcomes include: reducing opioid overdoses, increasing retention in treatment, reducing the length of time to relapse and prolonging recovery, and increasing number of individuals receiving MAT. It is estimated that SOR will serve 34,178 individuals during the first year and 68,356 individuals over the two-year project.
|1 H79 TI083291-01||
New Mexico (NM) is ideally positioned to expand its capacity to address the opioid use disorder crisis through implementation of evidence-based practices in prevention, treatment, recovery and harm reduction through use of the SOR funds. It will additionally include training and technical assistance to support agencies to address stimulant use disorder. The New Mexico State Opioid Response-2020 (NMSOR-2020) will continue to expand capacity to address OUD morbidity and mortality via the modified Hub and Spoke model (Collaborative Hubs Model) to support the adoption and implementation of EBPs statewide that have proven effectiveness to prevent, treat, support recovery and reduce harm related to OUD. NMSOR-2020 will support services across a broad range of ages, and cultural and ethnic groups, including Native American communities and Hispanic populations. The overarching goal of NMSOR-2020 is to reduce OUD rates and overdose deaths. To accomplish this, NMSOR-2020 has the following specific goals: (1) Increase access to medication-assisted treatment (MAT) using three FDA-approved medications for the treatment of OUDs; (2) Ensure MAT is comprehensive and includes FDA approved medications, therapy, and recovery supports; (3) Expand access to evidence-based prevention activities; (4) Expand tribal focused opioid use disorder education efforts; (5) Expand access to recovery services, including peer supports; and (6) Ensure continuous quality improvement through quality data collection, reporting & evaluation. We will accomplish these goals by expanding upon the NM Collaborative Hubs approach. Collaborative Hub partners will provide: Comprehensive MAT services for persons with OUD; Evidence based prevention services in primary and secondary schools; awareness and engagement in MAT using a statewide media campaign; Training in use of naloxone for harm reduction and engagement of survivors of overdose in MAT (buprenorphine and methadone treatments); Training and support to health care workforce (primary care, behavioral health, recovery), first responders on use of naloxone to help reverse overdose; and training in all components of MAT including DATA waiver, safer opioid prescribing, psychosocial supports (e.g. Motivational Interviewing, Community Reinforcement Approach, ASAM criteria 1-3) and recovery supports with a focus on expansion of peer recovery services. Training and technical assistance for providers/agencies will include Contingency Management to address stimulant use disorder and increase engagement in care. The GPRA tool will be collected on all individuals receiving treatment services through NMSOR, with 500 persons reached annually, and 1000 persons over the life of the 2 year grant.
|1 H79 TI083310-01||
The proposed State Opioid Response project aims to address the opioid and stimulant crisis in Nevada by increasing access to treatment, reducing unmet treatment need, and reducing opioid/stimulant overdose related deaths through the provision of prevention, treatment and recovery support activities for opioid use disorder and stimulant misuse. The complexity of the issues of opioid and stimulant use and addiction, both nationally and in Nevada, requires a multi-pronged approach that brings together prevention, early intervention, treatment, law enforcement, public policy, public health models, and recovery oriented systems of care. The crisis has highlighted continued opportunities for growth within state and local infrastructures that need to be brought together to develop a comprehensive, coordinated system of care. Nevadas vast geography and healthcare provider shortage contribute to a challenging environment to implement community-based strategies to combat the crisis. Stigma and lack of knowledge about available services continue to prevent individuals to seek treatment and physicians from linking and referring individuals to much needed opioid or stimulant use disorder treatment and recovery supports despite availability within treatment centers. Nevada has implemented a hybrid system of care to address the treatment needs for OUD Treatment and MAT Expansion. The following communities remain a of focus for State Opioid Response Grants (SOR) funding and includes: Pregnant and Post-partum women with OUD, and their newborns/dependents; Patients Reentering Communities from Criminal Justice, or other Rehabilitative Settings; Intravenous drug users and persons with OUD and co-morbidities, e.g. HIV/AIDS, Hepatitis C, and Tuberculosis; Veterans and Military personnel; and Aging Population with Intellectual and Developmental Disabilities. With this funding opportunity, Nevada will continue to address the unique needs of its communities and establish a long-term sustainable, coordinated, recovery-oriented system of care using the Collaborative Opioid Prescribing Model, overdose response and treatment engagement programs, overdose education and naloxone distribution, prescriber education and expansion of office based opioid treatment, recovery communities and peer supports, enhanced data collection, and information sharing between public health and law enforcement while maximizing existing resources including Medicaid reimbursement.
|1 H79 TI083327-01||
New York is a geographically, racially/ethnically, and socioeconomically diverse state of over 19 million residents. The populations of focus for New York's implementation if the State Opioid Response (SOR) II Grant are New Yorkers, located anywhere in the state, who: 1.a) have an untreated opioid use disorder (OUD) b) are at risk for developing an OUD; or c) are in recovery from an OUD; or 2.a) have an untreated stimulant use disorder b) are at risk for developing a stimulant use disorder; or c) are in recovery from a stimulant use disorder. New York proposed to build on past success by investing in services identified through regional networks that will oversee the continuation, and ongoing oversight of treatment-related projects as well as expand to fully integrate prevention and recovery services by supporting network and provider collaboration. The aim is to provide services across the continuum of care to create a wholistic approach to community intervention at the regional level. This includes utilizing measures to encourage network and provider collaboration to attain further increases in MAT initiation, MAT adherence, continuation of engagement in treatment, and continuity between levels of care, as well as demonstrably improved outreach to people who use opioids and/or stimulants who are not engaged in care. The network must also incorporate the full continuum of OASAS services by incorporating prevention and recovery into a more wholistic approach to community intervention. MAT in criminal justice settings and implementation of Contingency Management will also be areas of focus in enhancing treatment service to address opioid and stimulant disorder. Through regional networks, MAT in criminal justice settings and the implementation of contingency management OASAS will reach over 10,000 individuals per year with prevention, treatment and recovery services. Specific project reporting and GPRA data collection will be used to demonstrate the impact and effectiveness of this approach in improving patient outcomes.
|1 H79 TI083294-01||
Ohio’s State Opioid Response Project will achieve an integrated behavioral health system by increasing access to evidenced based prevention, early intervention, treatment, and recovery services. Innovative strategies to meet complex social needs are essential for long-term recovery of the target population, youth and adults diagnosed with an opioid, stimulant use or misuse disorder, and co-occurring mental illnesses. The geographic area for this project is state of Ohio with the goal of serving 20,000 Ohioans. The devastating and potential lasting effects of substance use across the lifespan continues to strain our families, ravage our communities, and threaten the well-being of our entire state. Substance use has major impacts creating multi-generational effects on children and adults mental, emotional and behavioral development.1 Family, community, and too often, older adults caring for children of substance use disordered parents are the unseen victims. While opioids are still cause for concern, current trends on the increased use of methamphetamines, marijuana and illicit drugs illuminate the spread of a drug problem that cannot be ignored2. The COVID 19 pandemic amplified the importance of addressing basic needs as modifiable risk factors which underpin mental and emotional as well as physical health. Addressing “complex social needs”, as well as, basic needs for food, safety, and housing require vision and leadership with the skills to work collectively to improve and change the way we serve the target population of this SOR 2.0 grant. Increasing access to interventions including Naloxone, Medication Assisted Treatments (MAT) are critical tools in our toolkit, communities must now begin addressing the “modifiable risk factors” and “complex social needs” of the target and special populations, such as preventing adverse childhood experiences, trauma, homelessness and substandard housing, unemployment, lack of education and job training, food scarcity, and isolation. SOR 2.0 will expand upon the proven success strategies of evidence-based treatment, by providing services to 20,000 Ohioans with treatment, MAT and recovery supports, but will aim higher to build and engage local and regional community partnerships in the places where we are all born, live, work, play. Essential community level partnerships are needed to scale-up supports Ohioans need to thrive across the lifespan. To be successful, regional partnerships must modernize approaches to sustain engagement and be inclusive of diverse partners such as community based, faith based and recovery community organizations, education and job training programs, public and supported recovery housing entities, public health including federally qualified health centers & behavioral health and social programs in addition to child welfare, early onset drug prevention programs that are youth-led and family and peer supported. 1 National Academies of Sciences, Engineering, and Medicine. 2020. The State of Mental, Emotional, and Behavioral Health of Children and Youth in the United States: Proceedings of a Workshop. Washington, DC: The National Academies Press. https://doi.org/10.17226/25739. 2 OSAM Report
|1 H79 TI083333-01||
The SOS initiative will serve individuals and their families across the lifespan affected by opioid and/or stimulant use disorder with a continued emphasis on adolescents, pre and post-natal mothers, Veterans and individuals who have served in the military, Native Americans, rural areas without access to treatment, and discharging from jail or prisons with Opioid or Stimulant Use Disorder. ODMHSAS will continue to utilize state and grant funding; align and streamline to maximize dollars used without duplication of efforts, and serve more individuals. SOS initiative will serve 5,000 in year 1 and 5,000 in year 2 with a total of 10,000 over two years. The SOS initiative goals encompass prevention services that will save lives in the future through decreasing opioid and heroin overdose, non-medical use of prescription drugs, methamphetamine, and other stimulants. SOS initiative will provide early and easy access to services through: outreach; early identification, and linkage to appropriate levels of treatment, crisis intervention, and recovery support services. Goals & Objectives: The following will be completed by the end of year one unless otherwise noted. 1) Increase community knowledge base to prevent abuse of opioids and increase access to services through messaging to 1000 individuals and practice facilitation; 2) Increase Community outreach by training, disseminate material, link referrals, and increase local action on opioid prevention; 3) Enhance the knowledge base for the workforce and better support individuals at risk or with an OUD, families and the community in prevention, treatment, and recovery supports through trainings, consultation, as well as the distribution of naloxone kits will reach approx. 10,900 individuals; 4) Promote social and emotional health for students to decrease disruptive behavior and increase quality instruction time to 100 classrooms; 5) Increase collaboration and sustain community referral base for individuals with OUD by mobilizing 4 regional OUD liaisons by conducting 800 contacts; 6) Increase access to an array of treatments for individuals with OUD/SUDs including those who are uninsured and underinsured, with emphasis on veterans, pregnant women, tribal, those coming out of jails and prisons through SBIRT and 23+providers serving 5,000 individuals; 7) Enhance the existing infrastructure to deliver evidence-based treatment interventions that include medication(s) FDA-approved for OUD, and stimulant misuse and use disorders, including for cocaine, methamphetamine, and/or co-occurring disorders including but not limited trauma, suicidal ideation in a continuum by using EBPs like Motivational Interviewing, telehealth, and recovery support strategies by 25% and developing Behavioral Health Center of Excellence. 8) Ensure contractors have a 100% of eligible prescribers on staff waivered to provided MAT services through TA provided waiver trainings; 9) Enhance Recovery Supports by increasing acceptance in Oxford Houses on MAT by 25%, train 100 PRRS’ in EBPs, provide support for 50 Certified Recovery Houses, IPS/housing services by 125% and use of CHESS app by 50%.
|1 H79 TI083316-01||
Oregon State Opioid Response Grant Oregon focused it's 2020 SOR grant to serve rural and frontier regions of the state that have high prevalence of Opioid and stimulant use and hospitalization. In addition, focus is also on certain frontier and urban regions where overdose is high yet diagnosis is low due to lack of access to treatment. The population of focus would be rural communities and other underserved communities such as people of color, those with low English proficiency, pregnant women and women with children who have SUD. Prevention strategies are geared towards adolescents in school, treatment strategies are geared towards individuals in need for Medication Assisted Treatment, and recovery strategies are geared towards long term recovery. Oregon aims to serve at least 2000 individuals over the course of two years with the SOR grant.
|1 H79 TI083297-01||
Pennsylvania proposes to address the opioid crisis and the increase of stimulant use by increasing access to treatment, reducing unmet treatment need, and reducing opioid overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder (OUD) and stimulant use disorder. The project will support a comprehensive response to the opioid epidemic and stimulant use increase using strategies to address identified needs along with the required activities of the grant. Strategies will include: Providing clinically appropriate treatment services to 3,500 individuals (7,000 during the project) who are under/uninsured; Continuation of the a hub and spoke model via the PA Coordinated Medication-Assisted Treatment program which plans to provide services to 3,600 individuals (7,200 during the project); Expand access to Medication-Assisted Treatment and stimulant use disorder treatment to individuals within the Criminal Justice System by providing services and utilizing Police Diversion programs to serve a combined total of 2,905 individuals (5,810 during the project). Expanding treatment capacity and recovery supports for special populations including 1,140 veterans (2,280 during the project), 814 pregnant women (1,628 during the project) and 2,000 homeless individuals (4,000 during the project); Establishment of Care Managers to assist 2,777 (5,554 during the project) individuals with navigation the treatment system, provide follow up care and community supports. Expansion of evidence-based prevention initiatives to educate 25,000 (50,000 during the project) parents and children; Increase in community awareness of OUD issues and resources through public awareness activities such as media outreach and stigma campaign; and Expansion of health promotion and harm reduction services to 66,660 (133,320 during the project) by supporting the Naloxone for First Responders Program.
|1 H79 TI083321-01||
The Puerto Rico (PR) Mental Health and Anti-Addiction Services Administration (MHAASA) proposes a 2-year SOR to reduce opioid addiction and overdose. Under Prevention, Naloxone distribution and training to first responders including Correction Officers and SA Peers; use of PDMP Red Flags for education of patients, physicians and pharmacists; and take-back of controlled medications are proposed. Treatment and Recovery to SA adults will be enhanced with MAT, WRAP, ORP, and RSHT EBP's, including male and parenting offender with OUD. Goal 1 is to reduce opioid overdose incidence in adults with SUD by implementing EB community prevention interventions. Objectives include: distribution of Naloxone with training on use to prevent opioid deaths, to 1,000 first responders, Corrections Officers, and SA Peers, 200 inmates post release and 300 pharmacists, to reduce by at least 15% overdose events in PR. Goal 2 is to increase access for adults with OUD/ODU to FDA approved MAT treatment, including SA inmates. Objectives include: opening 3 new OTP's to give access to MAT to at least 100 new clients with OUD: integrating WRAP EBP to complement MAT for adults with OUD/OD in 8 current, and 3 new, OTP's plus 3 SA Residential Treatment Centers (two for men and one for women), and 5 Drug Court Offices; Implementing a Pilot Project of treatments with Naltrexone and injectable Buprenorphine for 70 adults with OUD/ODU from MHAASA's Detoxification Unit in San Juan, and in SANOS FQHC of Caguas and the Pitirre CBO in Bayamon using physicians with DATA waiver; Implementing an ORP for 60 adults with OUD of the Ponce-500 Correctional Institution with integrated MAT, linking 90% to post-release MAT with recovery support services, and improving parenting skills and family support foe parenting offenders; and Testing 200 newly admitted patients in SA treatment for HIV with referral of positives, and vaccinating 3,000 SA clients at risk of Hepatitis. Goal 3 is to ensure peer counseling and coaching with community support services such as housing to adults with OUD to reduce relapse and criminal re-incidence. Objectives includes: Capacitating and certifying 40 recovered SA adults as Peer Specialist to implement the RTSH EBP with 750 adults with OUD discharged/referred from treatment; Achieving that at least 5% of participants receive stable housing; Provide 160 new enrollees contingency incentives to remain in treatment. This results in a total of 750 trainees receiving Naloxone and education on its use to prevent opioid overdose events per year and 1,500 by project end. It results in a total of 945 adults with OUD/ODU receiving treatment enhanced with EBP's by project end (440 in YR 01); 40 SA peers certified (20 per year) to provide peer counseling and coaching and 750 (375 per year) recovering clients receiving recovery group and RTSH EBP support services. A total 160 (80 per year) of new enrollees will receive contingency incentives to address travel, food and other barriers to participation. An evaluation team will be used to collect, analyze, and report process and outcome data quarterly.
|1 H79 TI083281-01||
The SOR-RI initiative will 1) reduce the number of prescription drug/opioid overdose-related deaths and adverse events among individuals 18 years of age or older, 2) increase access to treatment and reduce unmet needs through the provision of prevention, treatment, and recovery activities, and 3) support a comprehensive response using epidemiological data in the planning process. The grant will impact over 15,000 residents and provide direct services to 500 individuals annually. The goals of the initiative include: 1) Increase access to emergency services for Substance Use Disorder and related Behavioral Health issues, 2) Increase perception of harm associated with opioid use through increased access to prevention education in middle and high school populations, and 3) Increase recovery support services in the community. The SOR-RI initiative will target the entire state, with particular focus in regions with the highest rate of Emergency Department admissions for overdose (West Warwick, Cranston, Hopkinton, Providence, Johnston, Pawtucket, Westerly, and Warwick) and the highest rates of overdose deaths (Woonsocket, Providence, Central Falls, Pawtucket, Johnston, and North Providence), as reported by the Rhode Island Department of Health and the Medical Examiner's Office. These communities represent a combination of urban, suburban, and rural environments, and reflect a diverse population. Most overdose occur among adults, and approximately 3/4 of overdose-related deaths are in males.
|1 H79 TI083300-01||
The South Carolina Department of Alcohol and Other Drug Abuse Services (DAODAS), as the Single State Authority for substance use disorder (SUD) services, is requesting $17,931,882 a year for two years from SAMHSA's Center for Substance Abuse Treatment and Center for Substance Abuse Prevention under FOA# TI-20-012 to address the opioid and stimulant crisis by increasing access to treatment, reducing unmet treatment needs, and reducing opioid overdose-related deaths through the provision of prevention, treatment, and recovery activities for opioid and stimulant use disorders. DAODAS has partnered with Behavioral Health services Association of South Carolina Inc. (BHSA) and all 32 county alcohol and drug abuse authorities that provide substance use disorder prevention, intervention, treatment, and recovery-support services statewide; S.C. Association for The Treatment of Opioid Dependence and its members that operate opioid treatment programs in all regions of the state; the Medical University of South Carolina (MUSC); S.C. Department of Health and Environmental Control; S.C. Department of Corrections; S.C. Pharmacy Association; and Faces and voices of Recovery South Carolina. The application proposes a comprehensive response to the opioid and stimulant epidemic by: * conducting a thorough evaluation that will be the basis for strategic and sustainability plans; * addressing stigma and the need for action through a statewide multimedia campaign; * expanding and enhancing the state's Opioid Overdose Prevention Program; * providing financial assistance to indigent South Carolinians for medications and talk therapy; * expanding access to clinically appropriate, evidence-based practices for opioid and stimulant use disorders; * enhancing and expanding provision of peer support and other recovery-support services; * providing assistance to individuals returning to their communities from criminal justice settings; and * partnering with MUSC to expand medication-assisted treatment, and stimulant and opioid use disorder services across the state. (This initiative will include expanding the use of the MUSC Center for Telehealth and the expansion of the Project ECHO model).
|1 H79 TI083315-01||
South Dakota's State Opioid Response will expand upon infrastructure and capacity built through the State Targeted Response and SOR efforts in support of increased access to medication-assisted treatment, life-saving naloxone distribution, telehealth access to care, and workforce development and training. Furthermore, the state will utilize SOR funding to address stimulant use in addition to opioid use. As the Single State Authority, the South Dakota Department of Social Services, Division of Behavioral Health, will lead the project in collaboration with ongoing efforts with the South Dakota Department of Health (through Centers for Disease Control Data-Driven Prevention Initiative funding focused on prescription drug overdose), the Division's State SBIRT (Screening, Brief Intervention, and Referral to Treatment) Implementation grant, and community providers to identify, leverage, and enhance community-based resources in the areas of prevention, treatment, recovery, and peer support services. The project will be led by Kaitlyn Broesder, with enhanced project management through a contracted State Opioid Coordinator, supported by integration with a multidisciplinary team - the Opioid Abuse Advisory Committee - and key personnel to assess, identify, and support the implementation strategies that directly address these broad goals. Key outcomes of this two-year project will include empowered and engaged communities with increased awareness of the opioid and stimulant issues within our state, culturally responsive materials and strategies that can impact our most vulnerable populations, better equipped first responders to incidences of opioid overdose, extensive multidisciplinary training and curriculum supports in evidence-based prevention and treatment models, continued supports for enhanced access to Medication-Assisted Treatment through telehealth, enhanced supports for virtual support 'hub' and 'spoke' models (teleECHO clinics) to support staffing of complex OUD cases, intensive case management services, continuation of care coordination services and integration of onsite supporting services (e.g. peer coaching, case management) within primary- or SUD treatment agency-based care sites/clinics. An estimated 5,810 individuals are projected to be served by the project through training, the provision of treatment and/or peer recovery support services, primary prevention programming for middle- and high-school youth/implementation of an evidence-based early intervention program and/or through connection/referral to community-based resources and providers. As an estimate for general public impact/outcomes and loved ones of patients impacted are difficult to predict, these numbers are not included. However, metrics and outcomes for access to the Resource Hotline, the AvoidOpioidSD media campaign and care coordination services for loved ones will be tracked on a monthly basis. The vision is to ensure every individual being served or serving patients with OUD or stimulant use disorder is impacted by this project in South Dakota.
|1 H79 TI083307-01||
Tennessee Department of Mental Health and Substance Abuse Services (TDMHSAS), will work to enhance current prevention, treatment, and recovery activities in response to the opioid epidemic through TN SOR II: Changing Behavior, Coordinating Care and Changing Lives. TN SOR II will increase access to medication-assisted treatment (MAT), reduce unmet treatment need due to OUD and/or stimulant disorder, and reduce opioid overdose-related deaths. TN SOR II populations of focus are individuals at high risk of overdose, individuals with a diagnosis of opioid use disorder, and individuals with a diagnosis of stimulant use disorder. The geographic catchment area for TN SOR II is the State of Tennessee. TDMHSAS estimates that it will serve 2,007 individuals who have an OUD and/or stimulant use disorder through treatment and recovery activities. TDMHSAS expects to serve 4,014 individuals through the duration of TN SOR II. TN SOR II aims to: (1) increase the dangers of opioids and stimulants and of opioid overdose prevention resources, (2) educate key stakeholders on preventing overdose and on safety around illicit drugs, (3) reduce the number of overdose-related deaths through naloxone distribution, (4) train health professionals to assess and treat individuals with an OUD and/or stimulant use disorder, (5) reduce opioid overdose deaths through an Emergency Department Initiated Buprenorphine/Naloxone Pilot Program, (6) Expand access to MAT in rural areas of the state, (7) expand access to MAT for recovery court clients through a pilot to provide injectable buprenorphine; and (8) expand access to MAT, clinical treatment and recovery services through a Hub and Spoke model. TDMHSAS has established measurable objectives to ensure progress towards these goals, including providing opioid overdose prevention trainings to stakeholders, distributing approximately 50,500 naloxone overdose prevention kits annually to individuals at high overdose risk and their families/peers, and partner with physicians to participate in a multimodal training (i.e.ECHO) to provide OUD and stimulant use disorder related educational opportunities to health professionals. TN SOR II will implement prevention, treatment and recovery interventions to ensure a multipronged comprehensive response to opioid and/or stimulant misuse. TDMHSAS will employ evidence-based practices (EBPs) including community-based naloxone distribution, and MAT, which when combined with other EBPS improves retention in treatment and reduces the risk of relapse.
|1 H79 TI083288-01||
The Texas Targeted Opioid Response (TTOR) addresses the opioid crisis and rising trend in harmful stimulant use by reducing both unmet treatment need and overdose death. This is accomplished through the provision of prevention strategies that address overdose and harmful opioid and stimulant use, medication assisted treatment, medication assisted recovery support, and integrated prevention, treatment, and recovery projects. Five groups in Texas have been identified at highest risk for opioid use disorder, harmful stimulant use, and their consequences: 1) people living in major metropolitan areas, 2) pregnant and postpartum women, 3) justice-involved individuals, 4) people with a history of prescription opioid misuse, polysubstance use, or at risk of developing opioid use disorder, and 5) tribal communities. TTOR aims to continue its investments in prevention, treatment, and recovery services. These include a public education campaign promoting healthy behaviors and educating about the harms of opioid misuse, a statewide overdose prevention education and naloxone distribution program, maintained capacity expansion for opioid treatment services (both in clinic and office-based settings), treatment for comorbid conditions such as HIV and viral hepatitis, and a project to increase recovery support services that boosts peer support, housing, and re-entry recovery capital. Finally, TTOR will ensure continuity of care through integrated in-patient hospital settings, pre-arrest diversion, and community access programs that blend prevention, treatment, and recovery services that reduce barriers to access. Through partnerships with community agencies and governmental entities, such as public universities and city and county governments, TTOR will serve approximately 2,576,729 persons each year and 5,158,550 during the project period of September 1, 2020 through August 31, 2022.
|1 H79 TI083295-01||
The Utah State Stimulant and Opioid Response (UT SSOR) Grant, the Division of Substance Abuse and Mental Health (DSAMH) identifies youth ages 12-17 and adults ages 18 years and older, who have a current, or are at risk for an opioid use disorder (OUD) or stimulant use disorder as the population of focus. Priority populations will include pregnant women, individuals who use drugs intravenously, and people who are unfunded or uninsured. There will be UT SSOR projects throughout the state of Utah. The most recent death data available is from the state medical examiner's office indicates that in 2019 Utah had approximately 356 opioid-related overdose deaths. Opioids and psychostimulants, including methamphetamine, were listed on the health certificate as a contributing cause of death more often than any other drug types in 2019. There was a 38% increase in methamphetamine-involved overdose deaths from 2015 to 2019. Furthermore, methamphetamine was involved in 43% of all drug overdoses in Utah.
|UT||SALT LAKE CITY||$10,721,130|